SB 6210 authorizes Washington's health insurance exchange to add new certification criteria for health plans sold through the state marketplace, specifically to improve access and affordability for residents purchasing coverage via the exchange. The bill amends state law to let the exchange develop additional standards beyond the existing federal 19 criteria, focusing on cost and availability issues. It clarifies that the Insurance Commissioner retains primary oversight of rate increases and provider networks, which remain unchanged. This directly affects Washington residents who buy health insurance through the state exchange. The policy change aims to stabilize the insurance market without altering the Commissioner's existing responsibilities.
This bill expands eligibility for escorted leaves of absence for incarcerated individuals in Washington state. It allows incarcerated people to leave prison with supervision for specific reasons, including attending funerals or visiting seriously ill extended family (like grandchildren, aunts, uncles, or domestic partners), participating in athletic events, receiving medical care not available in prison, or joining nonviolent offender community service programs. The bill also requires reimbursement for leave costs from the incarcerated person or their family unless they are indigent, and prohibits leaving the state during these leaves. These changes apply to all state correctional facilities and modify existing state law to clarify permitted activities and financial responsibilities.
SB 5877 makes a technical correction to include certified anesthesiologist assistants explicitly in the existing $70 annual surcharge for license renewals. This surcharge, collected by the Department of Health, funds the physician health program and was previously only formally listed for physicians and physician assistants. The bill updates the language in three state code sections to ensure anesthesiologist assistants are clearly covered under the same surcharge mechanism. It does not change the surcharge amount, funding purpose, or requirements for anesthesiologist assistants. The correction ensures administrative accuracy for this specific healthcare profession.
SB 5904 restricts the use of specific nursing titles in Washington State. Only licensed registered nurses (R.N.), advanced practice nurse practitioners (A.P.R.N.), and licensed practical nurses (L.P.N.) may use those titles or their abbreviations. The bill prohibits all others - including unlicensed individuals and nonhuman entities - from using these titles or similar designations to imply licensed status. It includes an exception for Christian Science nurses listed in the Christian Science Journal, provided they do not claim to be licensed nurses. The law takes effect June 30, 2027.
Washington State's SB 5916 requires health plans and managed care organizations to treat nonopioid pain medications equally with opioids in coverage. Starting January 1, 2027, plans cannot label nonopioid drugs as "nonpreferred" when opioids are preferred, or apply stricter rules like prior authorization to nonopioids compared to opioids. The bill also mandates that the state develop an educational pamphlet about nonopioid pain treatment options, including their benefits and limitations. This directly affects health plans covering employees and their dependents, ensuring nonopioid alternatives face no coverage barriers relative to opioids.
SB 5924 would allow Washington pharmacists to prescribe medications and devices without needing separate collaborative agreements with doctors, expanding their current authority. This change directly affects pharmacists - particularly in rural and underserved communities - and patients who rely on access to care for chronic conditions like diabetes, cardiovascular disease, and behavioral health. The bill removes the administrative burden of maintaining collaborative agreements, which the legislature states has not improved patient safety or oversight, while recognizing pharmacists' existing 1,740+ hours of patient care training. The policy change aims to improve health outcomes by leveraging pharmacists' full scope of practice as highly trained providers.
SB 5947 establishes a 19-member Washington Health Care Board to design a universal health care plan for all state residents. The board must develop the plan, secure federal approval and funding through a waiver, and recommend legislative changes before implementation. It includes specific representation: employers, health providers (like primary care doctors and nurses), tribal leaders, labor, and health financing experts. The bill cannot take effect until federal law permits states to create such a plan with federal funding.
This bill updates the specific duties that various types of medical assistants, including certified, hemodialysis, phlebotomist, and registered medical assistants, are authorized to perform in Washington state. It details a range of tasks from fundamental procedures like sterilizing equipment and taking vital signs, to more advanced clinical duties such as performing venipuncture, administering certain medications, and assisting with minor office surgeries. The legislation also specifies limitations on these duties, such as restrictions on administering experimental drugs, and outlines supervision requirements by a healthcare practitioner for tasks like establishing intravenous lines or treating syphilis via telemedicine. By defining these roles, the bill impacts medical assistants and the healthcare practitioners who delegate and supervise their work.
HB 1574 expands "Good Samaritan" protections for individuals seeking or experiencing medical assistance during a drug-related overdose. The bill prevents these individuals from being arrested, charged, or prosecuted for drug possession if the evidence was obtained due to the overdose. It also protects them from civil forfeiture of property (with exceptions) and penalties for certain violations, such as probation or restraining orders, if these were discovered as a result of the overdose. Furthermore, it clarifies that these overdose protections can override mandatory arrest requirements for other offenses when the evidence is linked to the overdose and the need for medical assistance.
This bill aims to reduce prescription drug costs by improving patient access to biosimilar medicines and other prescribed drugs. It directly affects health plans, drug utilization management entities, patients, and healthcare providers. The bill establishes a clear process for patients and practitioners to request exceptions to prescription drug utilization management rules, such as prior authorization or step therapy. It outlines specific conditions under which these exception requests must be granted and sets strict deadlines for health plans to respond. If a response is not provided within the specified timeframes, the exception request is automatically granted, and health plans must cover an emergency supply fill if necessary during the process.